TERT and glioblastoma: Telomerase reverse transcriptase (TERT) promoter mutations are most commonly observed in malignant melanoma, uroepithelial bladder cancer, glioblastoma, mucinous liposarcoma, as well as in certain skin cancer and medulloblastoma subtypes.